Claritag Advanced Skin Tag Remover Kit
FDA-cleared for safe, effective use.
Works quickly, within 7-14 days.
Provides up to 10 treatment cycles.
We compared the top Skin Tag Remover products so you can quickly spot the strongest options for value, features, and everyday performance.
FDA-cleared for safe, effective use.
Works quickly, within 7-14 days.
Provides up to 10 treatment cycles.
Combines natural ingredients like thyme and tea tree.
Effective for multiple skin issues simultaneously.
Includes soothing egg yolk for calming effects.
Safe for both men and women.
Easy to use at home.
Effective on various skin types.
FDA cleared for safe skin tag removal.
Includes tweezers for precise application.
Provides eight applications for extended use.
Fast results in just one treatment.
Clinically proven and FDA-cleared.
Includes serum for enhanced effectiveness.
FDA cleared for safe skin tag removal.
Includes multiple tips for precise application.
Comes with protective SkinShields for treatment.
Adjustable speeds for personalized comfort.
USB rechargeable for convenient use.
LCD display ensures easy operation.
Oxygen-based formula for gentle cleansing.
Helps with occasional constipation relief.
Natural ingredients promote digestive health.
Easy application with convenient brush applicator.
Dries clear and stays waterproof.
Gentle yet effective 17% salicylic acid formula.
High salicylic acid concentration for effective removal.
Suitable for both men and women.
Works on plantar warts and corns.
Over-the-counter skin tag removal products typically work by freezing, applying heat, using chemicals, or other methods that damage tissue to remove or detach a skin growth. The key point is not to be swayed by labels claiming "fast," "painless," "natural," "clinically proven," or "FDA-cleared." Instead, focus on whether the product provides a specific treatment plan for a clearly identified skin tag, backed by sufficient information to minimize injury and supported by credible evidence.
Begin with proper lesion identification. The most reliable products specifically target common skin tags and specify suitable application areas, age restrictions, size, shape, color, texture, or attachments such as a narrow stalk. They also advise consulting a healthcare professional for moles, warts, changes, painful, dark, irregular, itchy, bleeding, crusted, infected, or uncertain growths. A vague claim encompassing multiple skin conditions—such as skin tags, warts, moles, freckles, spots, or calluses—does not replace the need for proper examination; these conditions are distinct, and treating the wrong type of growth can cause harm or delay diagnosis.
For freezing treatments, verify the product by checking the FDA 510(k) Premarket Notification Database for the exact trade name or model, confirm that the device is listed or identified in AccessGUDID with a matching device identifier or UDI, and ensure the labeling matches the product packaging. A clearance record should specify intended use, application design, treatment duration, age range, and relevant testing. The term “FDA-cleared” in marketing material is only valid if it corresponds to an exact product and manufacturer listed in public records. FDA clearance indicates the device is substantially equivalent to a legally marketed device but does not guarantee clinical efficacy or risk-free use.
Treatment control features are equally important as the mechanism of action. Look for details like a shield or holder, a tip that targets only the skin tag base, specified contact time, timing of activation, disposable applicators, and instructions for repeat treatments. For example, some cleared devices specify fixed protocols such as 20- or 40-second applications, but such parameters should not be assumed across different products. Adjustable intensity settings do not equate to validated dosage control unless output levels, handling procedures, and safety measures have been tested for that specific device.
Always review the full product label before purchasing. Cryogenic products should clearly specify the gas or propellant used, along with warnings about pressure, flammability, inhalation risks, eye injury, storage, and first aid. Chemical products should list active and inactive ingredients, their concentrations, contraindications, and exposure instructions. Additionally, supporting human studies specific to the product are more credible than testimonials or general category evidence. For example, research on salicylic acid for warts does not imply an untested liquid is effective for skin tags. Claims such as “one treatment,” “permanent removal,” “scar-free results,” and timelines of seven to fourteen days are often manufacturer assertions and may not be independently verified.
Safety considerations common across these products include avoiding use on areas with diabetes, poor circulation, cold sensitivity, impaired healing or sensation, immune suppression, or a history of abnormal scarring. Never apply these treatments to eyelids, near the eyes, on the face, genitals, mucous membranes, or other areas unless directed by a healthcare professional. Pressurized aerosols pose risks of frostbite, burns, scarring, eye injury, or fire; electrical devices can cause burns if their output and timing are not properly validated. When a growth is uncertain, changing, bleeding, painful, or resembles a mole, seeking professional medical assessment is the safest course of action.
The following topics differentiate a well-documented, regulated home treatment from a product with claims or ingredients that are hard to verify. Scores are evaluated in conjunction with the provided reviews: a high score indicates more robust evidence or protections, whereas a low score suggests a lack of transparency, conflicting information, or unverified product identity.
This metric evaluates how well instructions and design help prevent preventable injuries such as burns, frostbite, chemical burns, scarring, bleeding, infection, and other harm to individuals for whom home treatment is inappropriate. High-scoring examples specify restrictions based on age, health, treatment site, timing, and storage conditions; in contrast, lower-scoring products omit contraindications or do not clearly explain the mechanism and potential hazards. This is important because treatments involving freezing, acids, heat, or electricity can also harm healthy tissue if not properly guided.
This assesses whether the product is appropriate for common skin tags and advises users to consult a healthcare professional for moles, warts, or lesions that are changing, bleeding, painful, or uncertain, as well as for excluded sites. Higher scores are associated with targeted screening guidelines and referral recommendations. Lower scores are given when the listings promote the treatment of various growths, such as moles, without providing guidance on distinguishing benign skin tags from skin cancer or other lesions.
This assesses the product's ability to effectively contain freezing, heat, ligation, or chemical action within the tag area. Higher scores are achieved through the use of holders, shields, foam tips, disposable applicators, fixed contact times, and clearly defined activation procedures. Lower scores indicate issues such as unknown mechanisms, unverified adjustable settings, inconsistent formats, or missing instructions. Precision is crucial, as even minor errors can cause injury to the surrounding skin or eyes.
This assesses whether buyers can recognize active ingredients, concentrations, cryogens or propellants, flammability, and hazards related to first aid, storage, and disposal. Products that score highly disclose the specific gases or the complete formula along with relevant warnings. In contrast, lower-scoring products often merely mention a general ingredient, contain conflicting information about the propellant or concentration, or lack a safety data sheet altogether. Having this information is crucial before using a chemical or handling a pressurized container.
This assesses disposable tips, shields, plastics, aerosols, batteries, packaging, and the clarity of disposal instructions. High scores typically indicate the avoidance of pressurized aerosols or the provision of more comprehensive handling guidance, rather than confirming a low environmental impact product. Lower scores are associated with disposable canisters and applicators, unclear disposal methods for batteries or chemicals, and the absence of verified recycling, refilling, or end-of-life programs.
This assessment determines whether the specific product has a corresponding FDA clearance or device listing, including identifiable manufacturer, model, or UDI, and intended use. Products that receive high scores have a clear match between the product and its record, such as documented cryotherapy devices. Low scores indicate that the FDA claim is associated with a different product, manufacturer, unrelated clearance number, or lacks any public record. Merely having a brand-level claim is insufficient.
This assesses the evidence supporting the effectiveness and safe use of the same product, mechanism, delivery method, and protocol. High scores indicate regulator-reviewed testing or relevant independent evidence; however, even the more advanced cryotherapy products often did not have clinical trials specifically demonstrating removal outcomes for the exact product. Low scores are based on testimonials, research at the category level, or unsupported claims such as “clinically proven” or “one-treatment” assertions.
This assesses whether aspects such as speed, number of treatments, permanence, pain level, scar-free outcomes, clinical validation, and FDA claims align with the available evidence and authorized labeling. Products with high scores tend to adhere closely to their documented intended uses and recognize any uncertainties. Conversely, low-scoring products make claims about moles or genital warts, “no side effects,” or include statements about concentration and format that contradict the official label. A prominent result does not necessarily indicate typical success.
This assesses whether the claimed treatment counts, tips, activation procedures, shelf life, replacement parts, and instructions for repeat treatments align with what customers actually receive. High scores are awarded when there is a clear number of applications and a documented protocol, such as eight or ten specified treatments. Lower scores result when retail and clearance materials are inconsistent, capacity is solely based on seller claims, or there is no information provided about shelf life and repeat use.
This assesses whether the manufacturer can be identified, contacted, and is capable of providing up-to-date instructions, lot support, warranty details, recall responses, and adverse event management. High scores indicate a named manufacturer with a verified contact method supported by product documentation. Lower scores occur when the brand, labeler, or manufacturer varies across pages, support is merely a marketplace assurance, or current safety and lot information are unavailable.
The manufacturer provides a detailed list of ingredients and recommends performing a patch test before use. According to its current safety information, users should keep the salve away from the eyes and mucous membranes, only apply it externally, avoid using it on broken skin, and discontinue use if irritation or allergic reactions occur. This is important because topical tea tree oil can cause allergic contact dermatitis, and existing acne studies have used standardized 5% tea tree gel formulations, not this unspecified-concentration salve. The product does not contain any aerosol propellants, and the manufacturer states that it has a three-year shelf life, with an expiration date printed on each jar. There are no specific guidelines for recycling, packaging, or disposal of the product. The jar is a common personal-care container, and since it contains egg yolk extract and beeswax, it is not vegan. No recalls, warning letters, or adverse event reports related to this product have been found in the sources reviewed.
This product is ideal for adults seeking a small, leave-on ointment for occasional, localized bumps or post-shave ingrown hairs on healthy skin. It is suitable for those who can perform a patch test prior to regular use. The convenient format is perfect for individuals comfortable applying a visible layer morning and evening instead of a rinse-off product. Additionally, the ingredient list can assist buyers in checking for potential allergens such as egg, beeswax, tea tree, thyme, olive, or grapeseed components before using the body salve.
This product is not appropriate for individuals looking to remove skin tags or moles, or for treating uncertain, changing, bleeding, or infected lesions, or open skin wounds. Such cases require medical evaluation rather than a cosmetic ointment. Avoid using it if you have experienced reactions to tea tree oil, thyme, eggs, or bee products. The manufacturer’s current instructions also advise against use during pregnancy or breastfeeding. People with eczema, highly sensitive skin, asthma, or epilepsy should consult a healthcare professional before using this product.
There is no certification, clearance, clinical evidence for the specific product, recall history, or public safety documentation available. Although the marketplace listing claims it is safe, it does not provide instructions specifying appropriate lesion types, contraindicated sites, treatment limitations, or aftercare guidelines. Dermatology experts caution that growths can be misclassified, and that do-it-yourself skin-tag removal products may lead to injuries or scarring. Additionally, the inclusion of wart-removal options in the listing complicates safe usage since products for warts and skin tags are not interchangeable. Furthermore, environmental information is lacking. The product is described as a patch, but the listing does not specify the materials used in the patch, adhesive components, packaging materials, whether there are any single-use parts, or disposal instructions. It also fails to disclose if the product contains pressurized, chemical, or hazardous substances. Consequently, consumers are unable to assess the environmental impact or follow verified disposal procedures based on the information provided.
The information provided is suitable only for an adult buyer researching a compact, home-use skin product and who is willing to obtain additional safety and usage details directly from the seller before proceeding. The listing may appeal to someone looking for a patch-style treatment instead of visiting a clinic. However, due to inconsistent classification of warts and skin tags, the buyer should first verify the product’s exact mechanism, ingredients, target body areas, number of treatments, and contraindications. This product does not have independently verified suitability for specific tag sizes or locations.
It is not suitable for individuals who cannot confidently recognize a benign, typical skin tag, or for lesions that are changing, dark, bleeding, painful, infected, rapidly growing, or otherwise uncertain. Those with diabetes, poor circulation, impaired healing, immune suppression, a history of abnormal scarring, sensitive or broken skin, or those needing treatment on the face, eyelids, genitals, or mucous membranes should seek professional advice instead. Additionally, it is not appropriate for buyers who require disclosed ingredients, precise instructions, regulated traceability, or independently verified treatment results.
The product’s regulatory status in the United States is verifiable. The FDA approved this specific cryogenic skin-tag remover in November 2024, and its device listing indicates that Medtech Products is the registered manufacturer. Public clearance documents specify that the device contains dimethyl ether and propane in a nonrefillable aluminum canister, includes eight disposable foam tips and protective discs, and provides a home-use protocol. These documents also detail bench freezing tests, biocompatibility evaluations, and human-factors validation. A primary health consideration is that the cryogen is highly flammable and pressurized. Labels caution users to avoid heat, flames, sparks, inhalation, eye contact, puncturing, and incineration. They also warn that improper use can cause burns or scarring of healthy tissue. Each treatment utilizes a disposable foam tip and disc, and the aluminum aerosol canister must be disposed of according to local regulations. The EPA notes that any leftover or pressurized aerosol cans may need to be handled as household hazardous waste, depending on regional disposal rules.
This product is intended for adults aged 22 and older who can reliably identify a small, common, visible skin tag up to 3 mm in size on a suitable and easy-to-see area of the body. The user should have steady hand control, access to a timer, good lighting, and the ability to follow a set 40-second procedure without moving the applicator. It is best suited for individuals who understand that eight applications may treat fewer than eight skin tags if multiple treatments are necessary, and who can safely handle and store a flammable aerosol product.
This product is not suitable for children, pregnant or breastfeeding individuals, or people with diabetes, poor circulation, weakened immune systems, cold-sensitive blood conditions, bleeding issues, or those taking blood thinners. Do not apply it to moles, birthmarks, dark or hairy growths, unusual lesions, irritated or infected skin, or any growth with an uncertain appearance. It should also not be used on lesions located on the face, eyelids, eyes, ears, lips, mouth, nose, anus, genitals, buttocks, or hard-to-reach areas. Any changing, painful, bleeding, or suspicious growths should be evaluated by a healthcare professional.
Here is a rewritten version of the content in English, maintaining the key points: A key health benefit of this product is that it is not an untraceable cosmetic acid or ligation product. Its cryotherapy device is an FDA-cleared over-the-counter device, as confirmed by FDA records. The FDA summary includes details of biocompatibility testing, bench tests, a clinical study, and usability evaluations. Additionally, the product provides a comprehensive list of propellant and serum ingredients. Its labeling clearly restricts the size, appearance, and placement of tags, and specifies several medical contraindications. However, these safety measures do not eliminate all risks. FDA adverse event reports have documented serious injuries, including burns and discoloration, following use. The manufacturer was unable to inspect the returned device or determine a direct cause. The canister contains flammable substances such as dimethyl ether, propane, and isobutane. It must not be punctured, incinerated, heated, or used near open flames. The kit also generates waste through single-use applicators and the disposable pressurized canister, with only limited instructions provided for proper disposal at the end of its life.
This product is intended for use by adults who can reliably recognize a typical small skin tag that is soft, flexible, raised on a stalk, matches the color of nearby skin, and measures between 2 to 6 mm. The skin tag should be located in permissible areas such as the neck, chest, underarm, back, or groin. It is suitable for individuals capable of following step-by-step instructions accurately, using a new applicator for each treatment, avoiding heat and flames, and waiting two weeks before attempting any repeat treatment.
It is not suitable for anyone who is unsure whether a growth is a skin tag or for moles, or for lesions that are bleeding, painful, changing, dark, growing rapidly, or otherwise abnormal. Do not apply it to the eyelids or other areas that are excluded. The manufacturer advises against using it during pregnancy or breastfeeding, or if you have diabetes, poor circulation, cold-sensitive blood conditions, or a weakened immune system. Additionally, it is not appropriate for households that cannot safely store and handle a highly flammable pressurized canister away from children and ignition sources.
The regulatory record serves as a significant point of accountability. FDA device listing records identify Medtech Products as the registered manufacturer and link this specific product to a Class II cryosurgical device premarket submission. No product-specific FDA recall was found during the recall search conducted for this assessment. While FDA clearance differs from FDA approval, it confirms that the product has a verifiable device record, rather than relying solely on marketplace claims. Improvements are needed in safety disclosures. The manufacturer advises users not to touch the chilled tip, to ensure proper ventilation, avoid contact with eyes and flames, and to never puncture or burn the pressurized pen. However, the same page lists dimethyl ether and propane in the ingredient section while referencing nitrous oxide in the warnings. This inconsistency complicates the assessment of fire and disposal risks. Additionally, the kit generates waste through disposable foam tips, adhesive shields, and a pressurized pen. Users are instructed to discard tips and shields, but there are no detailed instructions provided for the proper disposal or end-of-life management of the pen itself.
This product is intended for adults aged 22 and older who have already identified a small, clearly visible skin tag and are able to follow time-sensitive instructions accurately. It is most suitable for individuals treating a limited number of tags, as the kit provides enough supplies for five applications, and a single tag may require multiple treatments. Users should be comfortable using a timer, working in a well-ventilated area away from ignition sources, applying the included shield tightly around the tag, and monitoring the treated area for two weeks to determine if additional treatment is necessary.
This product is not suitable for children or anyone uncertain if the growth is truly a skin tag. If you notice a lesion that is changing, dark, irregular, bleeding, painful, infected, or growing rapidly, or if it resembles a mole, it requires professional medical evaluation rather than home freezing. Do not use near the eyes or mucous membranes. Individuals who cannot safely operate a pressurized cryogenic device, follow the correct timing, or keep it away from children, flames, and inhalation risks should avoid using it. People with impaired healing or circulation should consult a healthcare professional before use.
The accessible product information describes this as an electric, USB-rechargeable pen equipped with interchangeable fine and coarse tips. It does not disclose details about aerosol propellants or topical active ingredients. However, information regarding the electrical mechanism, output, contact-tip materials, battery specifics, and end-of-life disposal instructions are not provided. While USB charging may potentially reduce battery waste compared to devices that use disposable batteries, this is an inferred benefit based on design rather than an official environmental certification. No specific FDA clearance, independent clinical trials, recalls, warning letters, or adverse event reports related to this product were found in the searched sources. The absence of such information does not imply the product is safe or effective. A concern exists regarding its marketing for mole removal and use on the face and body without clear safeguards or referral guidelines. The FDA has issued warnings that products claiming to remove moles and other skin lesions can cause injuries, scarring, and may delay the diagnosis of potentially cancerous lesions. Dermatology experts generally recommend professional evaluation over DIY mole removal.
This product is specifically designed for adults who have previously been confirmed by a healthcare professional to have a benign, small, typical skin tag. Users should understand that product-specific safety and effectiveness data are not available. It is intended for those seeking a rechargeable pen rather than an aerosol or chemical treatment. The user must have intact skin, be capable of following the comprehensive instructions provided, and be willing to stop use and consult a healthcare professional if they experience pain, bleeding, infection, uncertain results, or any changes in the lesion.
This product is not suitable for individuals who are considering treatment for a mole, changing or unusual spot, bleeding lesion, new growth appearing in adulthood, dark or irregularly shaped lesion, genital lesion, eyelid lesion, or any unidentified growth. It is also not appropriate for children, or for people with conditions such as diabetes, poor circulation, impaired healing, immune suppression, bleeding disorders, active skin infections, or a history of problematic scarring unless specifically advised by a qualified healthcare professional. Additionally, it should not be used as a replacement for a diagnostic examination or biopsy of a suspicious lesion.
The most prominent health fact is the high magnesium content. Four capsules deliver 1,537 mg of elemental magnesium, along with citric acid, organic gum acacia, and vegetarian capsules. The archived label advises individuals with heart or kidney conditions to consult a healthcare professional before use. Independent drug sources also identify magnesium oxide as a short-term laxative and warn of potential side effects such as cramping and diarrhea, as well as possible interactions with other medications. Extra caution is recommended for people with kidney, heart, liver, or intestinal issues. Manufacturers describe the product as vegan and gluten-free. The archived label states that the capsules are kosher-certified vegetarian; however, this does not guarantee that the final product is certified kosher or organic. The ingredients do not include aerosol cryogens, caustic skin-removal acids, or single-use treatment tips. Nonetheless, no specific disposal instructions or independent assessments of environmental impact were found. The bottle and capsules are typical household waste, and any unused contents should be kept out of reach of children.
This product is intended solely for adults looking for an oral magnesium oxide solution to help with occasional constipation or short-term bowel emptying, and is not suitable for treating visible skin growths. The 120-capsule package is ideal for individuals who can adhere to capsule dosing, drink a full glass of water, and stay close to a restroom afterward. Since the initial recommended dose provides 1,537 mg of elemental magnesium and may cause multiple bowel movements, it should only be used after consultation with a pharmacist or healthcare provider who has reviewed the person’s medications, medical history, and reasons for constipation.
This product is not intended for individuals looking to remove skin tags, moles, warts, or any lesions that are changing, bleeding, painful, pigmented, or uncertain. Such cases require a professional clinical evaluation rather than an oral colon-cleansing product. It is also not suitable for children under 18, as per the manufacturer's guidelines, and should only be used with medical advice during pregnancy or breastfeeding. Caution is advised for those with kidney, heart, liver, or intestinal conditions, high blood pressure, dehydration risks, or those taking other medications. Additionally, magnesium oxide may interact with certain medicines, which should generally be taken at least two hours apart.
The main active ingredient is salicylic acid, present at a concentration of 17%. According to FDA monograph guidelines, liquid salicylic acid products are approved for treating common and plantar warts, with instructions to apply a small amount directly to the wart. Evidence supports their use for non-genital skin warts; however, results may take several weeks to appear. Claims targeting genital warts pose significant safety concerns, as the FDA monograph explicitly prohibits this use. For this three-pack product, no complete label, safety data sheet, inactive ingredient list, or disposal instructions were found. This lack of information means safety aspects such as flammability, vapor exposure, eye safety, storage conditions, and disposal procedures are unverified. Additionally, the packaging—comprising three small liquid bottles—generates more waste compared to a single bottle. No recalls, warning letters, or independent test reports related to this product were identified in the sources reviewed, though this does not rule out the possibility that such information exists elsewhere.
This format is most suitable for an adult with a clearly identifiable common wart on the hand or a plantar wart on the sole of the foot. It is intended for careful application using a small brush, avoiding contact with normal skin to prevent spreading. The product is designed for repeated topical treatment rather than a single removal. The three 4 mL bottles may be appropriate for individuals treating multiple warts or undergoing a treatment course lasting several weeks. Usage should be based on the instructions provided in the complete Drug Facts label, which was not independently available for this product.
This product is not intended for the treatment of genital warts, facial warts, mucous membrane lesions, moles, birthmarks, hairy growths, bleeding or changing lesions, or any growth with an uncertain diagnosis. Such conditions require professional medical evaluation. Additionally, using salicylic acid wart removers for genital warts is contraindicated by FDA warnings. People with diabetes, poor circulation, infected, reddened, or irritated skin should avoid self-treating with this product without guidance from a healthcare professional. It is also not suitable for those seeking a fully documented formulation, independently verified treatment effectiveness, or specific safety and efficacy data associated with the product.
Salicylic acid is an evidence-supported keratolytic treatment for common and plantar warts. However, factors such as the concentration, delivery method, instructions, and warnings are important. The FDA's OTC wart-remover monograph allows for the use of 40% salicylic acid in plaster formulations. Although this product is marketed as a liquid, the available information does not include an accessible Drug Facts panel to confirm the formulation, complete ingredients, contraindications, dosing instructions, first aid guidelines, or storage recommendations. Notably, the mention of genital warts is particularly concerning, as the FDA monograph explicitly excludes the use of salicylic acid for genital warts. There is no evidence of aerosol or propellant components in this product. The available details suggest it is contained in a small liquid bottle, likely made of plastic. No verified recycling, hazardous waste, or disposal instructions were found. While the product marketing references essential oils, their specific identities and concentrations are not disclosed, which makes it difficult to assess potential fragrance sensitivities, environmental impact, or chemical disposal considerations.
This product is primarily intended for adults who have already identified a small, typical plantar wart or corn on intact foot skin and are aware that the product's 40% liquid claim raises unresolved regulatory and labeling issues. The small bottle may be suitable for individuals preferring a localized liquid treatment rather than a larger treatment kit. The user should have normal sensation and circulation in the treatment area, be able to avoid healthy skin, and should follow the instructions on the physical packaging rather than marketplace claims.
This product is not intended for skin tags, moles, birthmarks, changing or bleeding growths, facial lesions, mucous membrane lesions, or suspected genital warts. Dermatologists warn that wart removers can harm skin tags and may cause irritation or scarring. It should also not be used by individuals with diabetes, poor circulation, neuropathy, infected or reddened skin, or diminished ability to detect chemical injuries. Keep it out of reach of children, and do not use it if the diagnosis is uncertain or if home treatment has been unsuccessful.